Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of 4.5 Gram Methylprednisolone Administered Once Weekly for 12 Weeks on Bone Metabolism in Graves´ Ophthalmopathy

NCT03122847 is registered in ClinicalTrials.gov with Torben Harsløf as lead sponsor.

NCT NCT03122847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03122847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of 4.5 Gram Methylprednisolone Administered Once Weekly for 12 Weeks on Bone Metabolism in Graves´ Ophthalmopathy
Lead sponsor
Torben Harsløf
Phase
Observational
Overall status
Completed
Start date
June 7, 2017
Completion date
February 1, 2024
Enrollment
39 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graves ophthalmopathy